1. Home
  2. ANAB vs HLF Comparison

ANAB vs HLF Comparison

Compare ANAB & HLF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AnaptysBio Inc.

ANAB

AnaptysBio Inc.

HOLD

Current Price

$57.29

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Logo Herbalife Ltd.

HLF

Herbalife Ltd.

HOLD

Current Price

$12.35

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ANAB
HLF
Founded
2005
1980
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Pharmaceuticals
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.3B
IPO Year
2015
2004

Fundamental Metrics

Financial Performance
Metric
ANAB
HLF
Price
$57.29
$12.35
Analyst Decision
Buy
Strong Buy
Analyst Count
12
5
Target Price
$71.67
$18.00
AVG Volume (30 Days)
374.8K
1.5M
Earning Date
05-08-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
91.02
N/A
EPS
N/A
0.33
Revenue
$234,603,000.00
$5,037,500,000.00
Revenue This Year
N/A
$4.97
Revenue Next Year
$52.14
$3.80
P/E Ratio
N/A
$37.55
Revenue Growth
157.01
0.89
52 Week Low
$17.11
$7.56
52 Week High
$73.30
$20.40

Technical Indicators

Market Signals
Indicator
ANAB
HLF
Relative Strength Index (RSI) 50.01 50.69
Support Level $53.46 $11.43
Resistance Level $57.70 $13.16
Average True Range (ATR) 2.36 0.46
MACD 0.18 0.05
Stochastic Oscillator 41.32 62.05

Price Performance

Historical Comparison
ANAB
HLF

About ANAB AnaptysBio Inc.

AnaptysBio Inc is a clinical-stage biotechnology company. The company is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company is developing immune cell modulating antibodies, including two wholly owned checkpoint agonists in clinical-stage development, for autoimmune and inflammatory diseases; rosnilimab, PD-1 agonist in a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA) and a Phase 2 trial for the treatment of moderate-to-severe ulcerative colitis (UC); and ANB032, BTLA agonist, in a Phase 2b trial for the treatment of moderate-to-severe atopic dermatitis (AD).

About HLF Herbalife Ltd.

Herbalife Ltd is a health and wellness company. It provides health and wellness products in 95 markets through a direct-selling business model. Its product categories include Weight Management, Targeted Nutrition, Energy, Sports and Fitness, Outer Nutrition, and Literature, Promotional, and Other. Weight Management generates the majority of revenue, with products such as meal replacements, protein shakes, drink mixes, weight loss enhancers, and healthy snacks. Products are manufactured at facilities in Changsha and Suzhou, China; Lake Forest, California; and Winston-Salem, North Carolina, as well as by third-party providers. Revenues reflect sales to Members across North America, Latin America, EMEA, Asia Pacific, and China.

Share on Social Networks: